StockData

Bon Natural Life Ltd (BON) stock

BONNasdaqMedicinal Chemicals & Botanical ProductsFiscal year ends September 30
Financials through fiscal 2025, year ended Sep 30, 2025Last filing: 20-F on Jan 23, 2026Score 0/30
$1.07−0.02 (-1.83%)

Close on Nov 17, 2026Market cap $8.70MP/E –Yield –

Bon Natural Life price to sales ratio

The price-to-sales ratio is market cap divided by revenue over the trailing twelve months.

Bon Natural Life's price to sales ratio was 0.2× on Nov 11, 2026, against 0.0× a year earlier. Over the last 5 years it ranged from 0.0× to 421.5×, with a median of 4.6×.

Price to Sales Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2026Nov 11, 20260.2×−0.1
2025Dec 31, 20250.2×−7.1
2024Dec 31, 20247.4×+2.0
2023Dec 29, 20235.4×−68.8
2022Dec 30, 202274.2×−289.3
2021Dec 31, 2021363.5×–

More Bon Natural Life figures

See a number that looks wrong?